Apollon develops noninvasive continuous glucose monitoring systems.
Apollon has raised $1.7M in total funding. The most recent round was Seed. The last funding was announced in April 2024.
Apollon's investors include TIPS Program, KB Investment, BeHigh Investment, TheVentures, STIC Ventures.
Apollon is headquartered in Cambridge, United States.
Apollon develops noninvasive continuous glucose monitoring systems.
Apollon is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Apollon — Funding & Investors." VCBacked, April 8, 2024, https://www.vcbacked.co/company/apollon. Accessed July 19, 2026.
VCBacked. (2024). Apollon — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/apollon
{{cite web |title=Apollon — Funding & Investors |url=https://www.vcbacked.co/company/apollon |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated